These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34859345)
1. Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat. Sen R; Sengupta D; Mukherjee A Environ Sci Pollut Res Int; 2022 Sep; 29(41):62235-62247. PubMed ID: 34859345 [TBL] [Abstract][Full Text] [Related]
6. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598 [TBL] [Abstract][Full Text] [Related]
7. [Renin-angiotensin-aldosterone blockers and Covic-19 infection : friends or enemies ?]. Pechère-Bertschi A; Ponte B; Wuerzner G Rev Med Suisse; 2020 May; 16(693):1003-1007. PubMed ID: 32401442 [TBL] [Abstract][Full Text] [Related]
8. Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis. Aparisi Á; Catalá P; Amat-Santos IJ; Marcos-Mangas M; López-Otero D; Veras C; López-Pais J; Cabezón-Villalba G; Cacho Antonio CE; Candela J; Antúnez-Muiños P; Gil JF; González Ferrero T; Rojas G; Pérez-Poza M; Uribarri A; Otero-García O; García-Granja PE; Jiménez Ramos V; Revilla A; Dueñas C; Gómez I; González-Juanatey JR; San Román JA Med Clin (Barc); 2022 Apr; 158(7):315-323. PubMed ID: 34088524 [TBL] [Abstract][Full Text] [Related]
9. Association of Renin-Angiotensin-Aldosterone Inhibitors with COVID-19 Infection and Disease Severity among Individuals with Hypertension. Mahanaimy M; Finkel U; Barda N; Rottman E; Balicer R; Berliner Senderey A; Feldman B Isr Med Assoc J; 2022 May; 24(5):310-316. PubMed ID: 35598055 [TBL] [Abstract][Full Text] [Related]
10. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus]. Cano F; Gajardo M; Freundlich M Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500 [TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences. Dettlaff-Pokora A; Swierczynski J Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925881 [TBL] [Abstract][Full Text] [Related]
13. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19. Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967 [TBL] [Abstract][Full Text] [Related]
14. The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations. Maranduca MA; Vamesu CG; Tanase DM; Clim A; Drochioi IC; Pinzariu AC; Filip N; Dima N; Tudorancea I; Serban DN; Serban IL Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556919 [TBL] [Abstract][Full Text] [Related]
15. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance. Melissa Hallow K; Dave I Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503 [TBL] [Abstract][Full Text] [Related]
16. [ACE2 and coronavirus - a question of balance and dynamics?]. Lundström A; Sandén P Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329 [TBL] [Abstract][Full Text] [Related]
17. The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection. Schieffer E; Schieffer B J Renin Angiotensin Aldosterone Syst; 2022; 2022():2549063. PubMed ID: 35685188 [TBL] [Abstract][Full Text] [Related]
18. Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 disease. Zobel CM; Kuhn H; Schreiner M; Wenzel W; Wendtland J; Goekeri C; Scheit L; Oltmanns K; Rauschning D; Grossegesse M; Hofmann N; Wirtz H; Spethmann S; Virol J; 2024 Jan; 21(1):15. PubMed ID: 38200555 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 and hypertension. Ravichandran B; Grimm D; Krüger M; Kopp S; Infanger M; Wehland M Physiol Rep; 2021 Jun; 9(11):e14800. PubMed ID: 34121359 [TBL] [Abstract][Full Text] [Related]
20. Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review. Ferrari F; Martins VM; Fuchs FD; Stein R Clinics (Sao Paulo); 2021; 76():e2342. PubMed ID: 33852652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]